Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316

NCT02026349 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

860

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

DRUG: favipiravir
DRUG: Placebo

Sponsor

MDVI, LLC

Collaborators

[object Object]